COLL — COLLEGIUM PHARMACEUTICAL INC

Ownership history in Bayesian Capital Management, LP  ·  3 quarters on record

This page tracks every 13F SEC filing in which Bayesian Capital Management, LP reported a position in COLLEGIUM PHARMACEUTICAL INC (COLL). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.06% (2025 Q3)
Avg. % of fund
0.05%
First filed
2020 Q1
Last filed
2025 Q3
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 7,853 -538 -6.4% 0.06% $275K $34.99
2024 Q3 REDUCED 8,391 -5,909 -41.3% 0.04% $324K $38.64
2020 Q1 INITIATED 14,300 — — 0.05% $234K $16.33
% of Fund (quarterly)    COLL price (monthly, adj. close)

Other funds also holding COLL

As of 2025 Q4 — sorted by position size

Ballast Asset Management, LP 2.42% THIRD AVENUE MANAGEMENT LLC 3Y 7Y 1.71% Uniplan Investment Counsel, Inc. 3Y 7Y 1.39% EVENTIDE ASSET MANAGEMENT, LLC 3Y 7Y 1.36% EMERALD ADVISERS, LLC 3Y 7Y 0.9% Rubric Capital Management LP 3Y 7Y 0.83% SummerHaven Investment Management, LLC 3Y 0.68% Jackson Creek Investment Advisors LLC 3Y 0.53% Watershed Asset Management, L.L.C. 3Y 7Y 0.42% Values First Advisors, Inc. 3Y 0.41%
← Back to Bayesian Capital Management, LP Holdings